An estrogen-based therapy, called indazole chloride (IndCl), was shown to protect against optic nerve damage in a mouse model of multiple sclerosis (MS), a study reported. IndCl may help to improve vision in people with the disease, but early treatment could be essential, its researchers suggested. “Our study shows the optic nerve and optic tract, which undergo significant inflammation, demyelination, and axonal damage, are able to restore some function with IndCl treatment with successful attenuation in…

You must be logged in to read/download the full post.